| In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa A Zagzoog, KA Mohamed, HJJ Kim, ED Kim, CS Frank, T Black, ... Scientific Reports 10 (1), 20405, 2020 | 171 | 2020 |
| Application of fluorine-and nitrogen-walk approaches: defining the structural and functional diversity of 2-phenylindole class of cannabinoid 1 receptor positive allosteric … S Garai, PM Kulkarni, PC Schaffer, LM Leo, AL Brandt, A Zagzoog, ... Journal of medicinal chemistry 63 (2), 542-568, 2019 | 59 | 2019 |
| Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor A Zagzoog, AL Brandt, T Black, ED Kim, R Burkart, M Patel, Z Jin, ... Scientific Reports 11 (1), 10611, 2021 | 35 | 2021 |
| Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg AJ Roebuck, Q Greba, TJ Onofrychuk, DL McElroy, TM Sandini, ... European Journal of Neuroscience 55 (4), 1063-1078, 2022 | 30 | 2022 |
| Discovery of a biased allosteric modulator for cannabinoid 1 receptor: preclinical anti-glaucoma efficacy S Garai, LM Leo, AM Szczesniak, DP Hurst, PC Schaffer, A Zagzoog, ... Journal of Medicinal Chemistry 64 (12), 8104-8126, 2021 | 29 | 2021 |
| Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes HJJ Kim, A Zagzoog, T Black, SL Baccetto, UC Ezeaka, RB Laprairie Pharmacology research & perspectives 10 (3), e00950, 2022 | 21 | 2022 |
| Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules A Zagzoog, A Cabecinha, H Abramovici, RB Laprairie Frontiers in Pharmacology 13, 956030, 2022 | 20 | 2022 |
| The endocannabinoid system and synthetic cannabinoids in preclinical models of seizure and epilepsy AM Smolyakova, A Zagzoog, AL Brandt, T Black, K Mohamed, ... Journal of Clinical Neurophysiology 37 (1), 15-27, 2020 | 18 | 2020 |
| Indomethacin enhances type 1 cannabinoid receptor signaling RB Laprairie, KA Mohamed, A Zagzoog, MEM Kelly, LA Stevenson, ... Frontiers in Molecular Neuroscience 12, 257, 2019 | 13 | 2019 |
| Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure T Black, SL Baccetto, IL Barnard, E Finch, DL McElroy, FVL Austin-Scott, ... Scientific Reports 13 (1), 21070, 2023 | 12 | 2023 |
| In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors HJJ Kim, A Zagzoog, AM Smolyakova, UC Ezeaka, MJ Benko, T Holt, ... Frontiers in Neuroscience 15, 790546, 2021 | 11 | 2021 |
| Dual cannabinoid and orexin regulation of anhedonic behaviour caused by prolonged restraint stress HJJ Kim, A Zagzoog, C Ceni, R Ferrisi, N Janz, RB Laprairie Brain sciences 13 (2), 314, 2023 | 10 | 2023 |
| The effects of acute Cannabis smoke or Δ9-THC injections on the trial-unique, nonmatching-to-location and five-choice serial reaction time tasks in male Long-Evans rats IL Barnard, TJ Onofrychuk, TM Sandini, DL McElroy, A Zagzoog, ... Neurobiology of learning and memory 192, 107624, 2022 | 10 | 2022 |
| Molecular and cellular mechanisms underlying brain region-specific endocannabinoid system modulation by estradiol across the rodent estrus cycle HJJ Kim, A Zagzoog, T Black, SL Baccetto, RB Laprairie Progress in Molecular Biology and Translational Science 195, 27-45, 2023 | 7 | 2023 |
| The Intoxication Equivalency of 11-Hydroxy-Δ9-Tetrahydrocannabinol Relative to Δ9-Tetrahydrocannabinol A Zagzoog, K Halter, AM Jones, N Bannatyne, J Cline, A Wilcox, ... The Journal of Pharmacology and Experimental Therapeutics 391 (2), 194-205, 2024 | 4 | 2024 |
| Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593 AL Brandt, S Garai, A Zagzoog, DP Hurst, LA Stevenson, RG Pertwee, ... Frontiers in Pharmacology 13, 919605, 2022 | 3 | 2022 |
| Sex-specific differences in rotarod performance and type 1 cannabinoid receptor levels in a rat model of traumatic brain injury treated with Δ9-tetrahydrocannabinol T Black, A Zagoog, AJ Roebuck, Q Greba, JP Neary, JG Howland, ... bioRxiv, 2022.04. 11.487790, 2022 | 1 | 2022 |
| Determination of the Negative Allosteric Binding Site of Cannabidiol at the CB1 Receptor: A Combined Computational and Site-Directed Mutagenesis Study P Pandey, A Zagzoog, RB Laprairie, WM Neal, RJ Doerksen, ... ACS Chemical Neuroscience, 2025 | | 2025 |
| Pharmacodynamics and Pharmacokinetics for Selected Cannabinoids A Zagzoog | | 2024 |
| Dual Cannabinoid and Orexin Regulation of Anhedonic Behaviour Caused by Prolonged Restraint Stress. Brain Sci. 2023, 13, 314 HJJ Kim, A Zagzoog, C Ceni, R Ferrisi, N Janz, RB Laprairie | | 2023 |
